Volume 1, Issue 1 (Avicenna Journal of Pharmaceutical Research, Jun 2020)                   Avicenna J Pharma Res 2020, 1(1): 24-32 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khoshyari S, Mahjub R. Preparation, Box-Behnken Statistical Optimization, and In Vitro Characterization of a Self-nanoemulsifying Drug Delivery System for the Oral Delivery of Budesonide as a Poorly Soluble Drug. Avicenna J Pharma Res 2020; 1 (1) :24-32
URL: http://ajpr1.umsha.ac.ir/article-1-48-en.html
1- Department of Pharmaceutics, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
Abstract:   (34 Views)

Background: Self-nanoemulsifying drug delivery systems (SNEDDS) can be used to improve the oral bioavailability of lipophilic drugs. The aim of this study was the preparation and characterization of a SNEDDS for the oral delivery of budesonide as a poorly soluble drug.

Methods: To prepare SNEDDS, budesonide (20 mg) was dissolved in the mixture of liquid paraffin, Tween 80, and propylene glycol, followed by using the Box-Behnken response surface methodology for statistical optimization. The prepared mixtures were then diluted in the simulated intestinal fluid (SIF) and their physico-chemical characteristics were studied as well. Then, SNEDDS were morphologically evaluated using transmission electron microscopy (TEM). Finally, the in vitro release profile of budesonide from nano-droplets was determined in the SIF.

Results: Based on the results, the size, polydispersity index, zeta potential, and entrapment efficiency of statistically optimized SNEEDS were reported as 146±37 nm, 0.211±0.06, +3.6±0.84 mV, and 94.3±6.58%, respectively. In addition, TEM images revealed spherical nano-droplets. Further, the release profile of budesonide from nano-droplets exhibited 33.81±1.67% of drug release in SIF during 360 minutes of incubation at 37° C, indicating sustained drug release.

Conclusion: The obtained data demonstrated that SNEDDS could be regarded as a good candidate for oral delivery of budesonide as a poorly water-soluble drug representing a high first-pass metabolism.

Full-Text [PDF 828 kb]   (34 Downloads)    
Type of Study: Research | Subject: General
Received: 2026/09/28 | Accepted: 2020/08/31 | Published: 2026/09/28

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Avicenna Journal of Pharmaceutical Research

Designed & Developed by : Yektaweb